These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12113896)

  • 1. Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex.
    Jones LB; Johnson N; Byne W
    Psychiatry Res; 2002 Jul; 114(3):137-48. PubMed ID: 12113896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
    Broadbelt K; Jones LB
    J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of altered neurogranin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
    Broadbelt K; Ramprasaud A; Jones LB
    Schizophr Res; 2006 Oct; 87(1-3):6-14. PubMed ID: 16797925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex.
    Broadbelt K; Byne W; Jones LB
    Schizophr Res; 2002 Nov; 58(1):75-81. PubMed ID: 12363393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea.
    Somenarain L; Jones LB
    J Psychiatr Res; 2010 Aug; 44(11):694-9. PubMed ID: 20092829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 2000 Jan; 57(1):65-73. PubMed ID: 10632234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early postnatal lesion of the medial dorsal nucleus leads to loss of dendrites and spines in adult prefrontal cortex.
    Marmolejo N; Paez J; Levitt JB; Jones LB
    Dev Neurosci; 2012; 34(6):463-76. PubMed ID: 23406908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.
    Benes FM; Vincent SL; Marie A; Khan Y
    Neuroscience; 1996 Dec; 75(4):1021-31. PubMed ID: 8938738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression.
    Law AJ; Harrison PJ
    J Psychiatr Res; 2003; 37(6):487-99. PubMed ID: 14563380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure.
    Jones L; Fischer I; Levitt P
    Cereb Cortex; 1996; 6(3):431-45. PubMed ID: 8670669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex.
    Yang CR; Seamans JK; Gorelova N
    Neuropsychopharmacology; 1999 Aug; 21(2):161-94. PubMed ID: 10432466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.
    Selemon LD; Rajkowska G; Goldman-Rakic PS
    Arch Gen Psychiatry; 1995 Oct; 52(10):805-18; discussion 819-20. PubMed ID: 7575100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia.
    Rioux L; Ruscheinsky D; Arnold SE
    Psychiatry Res; 2004 Aug; 128(1):1-7. PubMed ID: 15450909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.
    Akil M; Pierri JN; Whitehead RE; Edgar CL; Mohila C; Sampson AR; Lewis DA
    Am J Psychiatry; 1999 Oct; 156(10):1580-9. PubMed ID: 10518170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients.
    Kalus P; Müller TJ; Zuschratter W; Senitz D
    Neuroreport; 2000 Nov; 11(16):3621-5. PubMed ID: 11095531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.
    Pierri JN; Chaudry AS; Woo TU; Lewis DA
    Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia.
    Kirkpatrick B; Messias NC; Conley RR; Roberts RC
    J Nerv Ment Dis; 2003 Sep; 191(9):563-7. PubMed ID: 14504564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent cytoarchitechtonic changes in the prefrontal cortex of schizophrenics.
    Jones LB
    Front Biosci; 2001 Nov; 6():E148-53. PubMed ID: 11689353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.